Daiwa Corporate Investment Establishes Venture Capital Firm Specializing in Biopharmaceuticals; Sights Set on Seeds of University Origin

DCI Partners CEO Hiroki Narita Daiwa Corporate Investment (DCI) has established DCI Partners, a venture capital subsidiary that will specialize in biopharmaceuticals. With the favorable conditions created by government measures to support the pharmaceutical industry, DCI expects many promising seeds...read more